While online streaming is no doubt convenient and affordable compared with physical media, many of us still prefer owning a physical object like CDs for our music collection. CDs are reliable, they're ...

Streaming and vinyl may be all the rage, but there are plenty of us who have never let go of our CD collection and enjoy listening to and buying CDs to this day. What Hi-Fi? has been testing and ...

The French pharmaceutical group’s board is scheduled to meet to discuss the planned transaction and finalize measures with CD&R to protect jobs and local plants, the people said, asking not to ...

Credit: jd8/Shutterstock. Sanofi has announced negotiations with Clayton Dubilier & Rice (CD&R), a US-based investment company, regarding the potential sale of a 50% controlling stake in its consumer ...

The French finance ministry said in a statement that CD&R was a "serious investment fund" with positive prospects for Opella's development and its plants in France. It added that it would require ...

Bloomberg previously reported PE firms CD&R and PAI Partners submitted bids before a recent deadline. The latest update comes after a report from Bloomberg last week that potential bidders for ...

Sanofi's negotiations with CD&R show the Paris-based company is following a different path to exit the business, though. The company said Friday that it is in discussions with New York-based CD&R ...

In September, Bloomberg reported that Sanofi had received two separate bids from CD&R and rival PAI Partners for the Opella unit. CD&R has kept away interest from rival PAI Partners for the unit ...

Clayton Dubilier & Rice is nearing a deal to acquire Sanofi’s consumer health unit for about €15 billion ($16.4 billion), in what would be one of the largest European transactions this year ...

Private equity firm sees off rival bidder PAI Partners Sanofi is likely to retain a minority stake in Opella unit Clayton Dubilier & Rice is nearing a deal to acquire Sanofi ’s consumer health unit ...

(Reuters) -Sanofi is closing in on a deal to sell its consumer health unit for about 15 billion euros ($16.4 billion) to U.S. private equity firm Clayton Dubilier & Rice (CD&R), a person familiar ...